Addressing reimbursement disparities for direct-acting antiviral therapies for hepatitis C virus infection is essential to ensure access for all

J. Grebely, A. Litwin, G. J. Dore

Research output: Contribution to journalComment/debatepeer-review

4 Scopus citations
Original languageEnglish (US)
Pages (from-to)664-666
Number of pages3
JournalJournal of Viral Hepatitis
Issue number9
StatePublished - Sep 1 2016


  • IFN-free
  • PWID
  • drug users
  • hepatitis C virus
  • injecting
  • injection

ASJC Scopus subject areas

  • Hepatology
  • Infectious Diseases
  • Virology

Cite this